Acute / early HIV infection - recognition & treatment
Acute HIV · Infectious Disease
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Acute retroviral syndrome (seroconversion illness): a mononucleosis-like illness ~2-4 weeks after exposure - fever, rash, pharyngitis, lymphadenopathy. Patients are highly infectious. A 4th-generation Ag/Ab test can be negative in the earliest window, so diagnose with HIV RNA. Treat all - start ART as soon as possible (even same day).
Red flags
- Aseptic meningitis / encephalitis
- Severe or prolonged symptoms; very high viral load
- Pregnancy
- Opportunistic infection suggesting advanced disease
- Recent long-acting cabotegravir PrEP (INSTI resistance risk)
Assessment
Differential diagnosis
- EBV / CMV mononucleosis
- Influenza / other acute viral illness
- Secondary syphilis
- Streptococcal pharyngitis
- Drug reaction
- Acute toxoplasmosis
- Dengue / other travel-related febrile illness
Investigations
- 4th-generation HIV Ag/Ab combination test AND HIV RNA (viral load) - RNA needed because antibody may be negative in early infection
- Confirm/repeat per testing algorithm
- Baseline CD4, HIV resistance genotype
- HBV/HCV and STI screen
- Pregnancy test in those of childbearing potential before ART
Management
- Consider acute HIV in anyone with a mono-like/febrile illness +/- rash and risk factors - do not miss it (antibody may be negative)
- Send HIV RNA, not antibody alone
- Counsel on very high transmissibility
- Treat all - start ART as soon as possible (even same-day); do not delay for resistance results
- Choose an integrase-based regimen; if recent long-acting cabotegravir PrEP exposure, use a boosted PI pending genotype
- Link urgently to HIV care; partner notification and PEP/PrEP counselling
Drugs & doses
Bictegravir/tenofovir-AF/emtricitabine - preferred single-tablet regimen
OR dolutegravir + tenofovir (DF or AF) + (emtricitabine or lamivudine)
Boosted darunavir + tenofovir + (FTC or 3TC) - if INSTI resistance concern (e.g. partner failing an INSTI regimen, or recent long-acting cabotegravir PrEP exposure) pending resistance results
Start ART as soon as possible (even same-day); continue indefinitely without interruption
Standard adult fixed-dose combinations - per-mg doses not itemised in source
Disposition
Urgent HIV/ID linkage for same-day/rapid ART start; admit if neurologic involvement or OI; public-health partner notification.
Complications & pitfalls
- Ongoing onward transmission
- Disease progression
- Rare acute-phase opportunistic infections
- Neurologic involvement (aseptic meningitis)
Exam pearls
- In early infection the antibody test can be negative - order HIV RNA whenever you suspect seroconversion
- Treat all and start ART immediately - improves outcomes, shrinks the reservoir, and cuts transmission
- Recent long-acting cabotegravir PrEP exposure -> favour a boosted PI pending genotype
- Do not delay ART for resistance results; adjust later if needed
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.